Welcome to our dedicated page for Cycurion news (Ticker: CYCUW), a resource for investors and traders seeking the latest updates and insights on Cycurion stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cycurion's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cycurion's position in the market.
Cycurion (NASDAQ: CYCU)reverse stock split effective at the opening of trading on October 27, 2025, with shares to trade on a split-adjusted basis under the existing symbol CYCU.
The split reduces outstanding common shares from approximately 86,533,435 to approximately 2,884,447, assigns CUSIP 95758L305, and leaves the total number of authorized shares and par value unchanged.
No fractional shares will be issued; stockholders entitled to fractional shares will receive a cash payment based on the closing price on the trading day before the effective date (without interest and subject to withholding). Equiniti Trust Company will handle certificate exchanges. Proportionate adjustments will be made to outstanding warrants, options, and restricted stock awards.
IQSTEL (NASDAQ:IQST) and Cycurion (NASDAQ:CYCU) completed Phase One of a joint program delivering AI-enhanced cybersecurity for telecom and enterprise AI agents on Oct 21, 2025. Phase One is live and adds a Model Context Protocol (MCP) interface for Airweb.ai and IQ2Call.ai, and places those agents behind Cycurion’s ARx multi-layer platform.
Key live features include an ARx reverse-proxy shield, a four-layer defense (geo-gating; WAF & API security; proprietary bot hunter; AI behavioral analysis), a dynamic threat intelligence blocklist of 13M+ malicious IPs, and operational visibility via dashboards and SIEM integration.
Cycurion (NASDAQ: CYCU) received a Delisting Determination Letter from Nasdaq staff dated October 14, 2025, initiating proceedings to delist its common stock for failing to meet the $1.00 bid price requirement. The company did not regain compliance by the October 6, 2025 deadline.
Cycurion requested an appeal on October 20, 2025, which stays suspension and the Form 25-NSE filing pending a Hearings Panel decision (hearings typically occur ~30–45 days after request). The board approved a 30:1 reverse stock split on October 10, 2025, expected to take effect on October 27, 2025. If delisted, shares may move to the over-the-counter market, which is likely to be less liquid.
Cycurion (NASDAQ: CYCU) announced five new contracts closed in September 2025 totaling approximately $1 million, expected to add about $75,000 in monthly recurring revenue. Four of the contracts are in the healthcare and pharmaceutical sectors, and the company cites its relationship with NACCHO as a contributor to those wins.
The deals deploy Cycurion’s Cyber Shield suite and signal an explicit push into commercial and non‑government markets, supporting the company’s stated strategy to broaden customers and sustain revenue growth. Management says further expansions will be announced in coming quarters.
Cycurion (NASDAQ: CYCU) announced on October 14, 2025 that its cybersecurity team has spent the past 5–6 months monitoring online platforms and gathering evidence of alleged defamatory posts and coordinated misinformation targeting the company and its executives. The company said it identified substantial information and has engaged counsel to pursue legal remedies, including steps to file a John Doe lawsuit to identify those responsible.
Cycurion also reported indications of a significant naked short position that may involve unlawful manipulation and said it is collaborating with platforms and authorities to protect shareholders and the integrity of its securities.
Cycurion (NASDAQ:CYCU) has secured $4.6 million in new contracts, expanding its total contract portfolio to $73.6 million. The new contracts, set to begin in September 2025, span across multiple sectors including government, healthcare, and public safety.
The Company's AI-enhanced Cyber Shield / ARx platform is driving over 15 engagements with contract durations of 1-10 years. The new contracts are expected to generate $2.1 million in Q3 2025 and an additional $2.5 million in Q4 2025. Key initiatives include AI-powered cybersecurity services for county governments, healthcare organizations, and federal agencies.
Cycurion (NASDAQ: CYCU) and IQSTEL (NASDAQ: IQST) have executed a $1 million stock exchange agreement to strengthen their strategic alliance in AI-driven cybersecurity. Each company will issue $1 million worth of common stock to the other, with share prices determined by the lower of the Nasdaq closing price on September 2, 2025, or the 5-day average preceding that date.
Both companies plan to distribute up to 50% of received shares as dividends to their respective shareholders, creating cross-ownership opportunities. The alliance combines IQSTEL's global telecom platform serving 600+ operators with Cycurion's AI cybersecurity expertise in U.S. government markets. The partnership aims to develop advanced AI-driven cybersecurity solutions and facilitate cross-selling opportunities.
Cycurion (NASDAQ: CYCU), a cybersecurity and IT solutions provider, announced its participation in the H.C. Wainwright 27th Annual Global Investment Conference. The event will take place at the Lotte New York Palace Hotel from September 8-10, 2025.
CEO Kevin Kelly and CFO Alvin McCoy will deliver a corporate overview presentation, which will be available on-demand starting at 7:00 AM Eastern Time on September 5, 2025. The presentation will be accessible via webcast on Cycurion's investor relations website, with a replay available for approximately 90 days. The executives will also be available for one-on-one meetings during the conference.
Cycurion (NASDAQ: CYCU) has successfully regained compliance with multiple Nasdaq listing requirements. The company received formal notification on August 19, 2025, confirming compliance with the stockholders' equity requirement by maintaining over $10 million in equity ($10,448,853 as of June 30, 2025).
Additionally, Cycurion met the market value of publicly held shares (MVPHS) requirement by maintaining a value of $5 million or greater for 10 consecutive business days from August 5-18, 2025. These developments resolve previous compliance issues, including an April 2025 notification regarding insufficient market value of listed securities.
Cycurion (NASDAQ: CYCU), a cybersecurity and IT solutions provider, has announced a significant $69 million contracted backlog with multi-year contracts spanning 1-5 years. The company, currently operating at a $16 million annualized revenue run-rate, expects growth in 2026 despite challenges from DOGE impacts in 2025.
CEO Kevin Kelly emphasized the company's potential for revenue growth and positive adjusted EBITDA in coming quarters. Cycurion's strategic partnerships with iQSTEL and LSV Tech, along with access to 3,500 state and local healthcare associations through NAACHO, position the company for future growth. The backlog is additional to existing revenue-generating business, though revenue recognition has been limited due to work initiation delays.
FAQ
What is the current stock price of Cycurion (CYCUW)?
